Logo Image
News
All NewsDosing & Delivery InnovationsPress ReleasesProduct Approvals and Launches
Video
All Video TypesAJMC TVGuidelinesInsightsOnLocationPayer PerspectivesPeer ExchangePost Conference PerspectivesShortsStakeholder Summit
Podcasts
Journals
All JournalsThe American Journal of Managed CarePopulation Health, Equity & OutcomesEvidence-Based OncologyAbout Supplements and Featured PublicationsSupplements and Featured Publications IssuesSubmit a Manuscript
More
Conferences
Conference CoverageConference ListingPost Conference Perspectives
Events
AJMC EventsEvents CalendarInstitute for Value-Based MedicinePatient-Centered Oncology CarePopulation Health RoundtablesWebinars
Resources
Interactive ToolsFormulary CentralClinical SpotlightMicrositesSponsored Content
CE
About AJMC
AJMC StaffAnniversarySeema Sonnad AwardStrategic Alliance Partners

Subscribe

  • News
  • Video
  • Podcasts
  • Journals
  • Conferences
  • Events
  • Resources
  • CE
  • About AJMC
  • Subscribe
  • Biosimilars
  • Cardiorenalmetabolic
    • Cardiomyopathy
    • Cardiovascular
    • Chronic Kidney Disease
    • Diabetes
    • Heart Failure
    • Type 1 Diabetes
  • Dermatology
    • Alopecia
    • Atopic Dermatitis
    • Chronic Hand Eczema
    • Psoriasis
  • Gastroenterology
  • Hematology
    • ALL/AML
    • CLL/SLL
    • GVHD
    • Hemophilia
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myelodysplastic Syndromes
    • Myeloproliferative Neoplasms
    • Non-Hodgkin Lymphoma
    • Rare Blood
  • Hepatology
    • Hepatitis
    • Liver
    • MASH
  • Immunology
    • Allergy
    • Autoimmune
    • Inflammation
    • Lupus
    • Myasthenia Gravis
    • Rheumatoid Arthritis
  • Infectious Disease
    • COVID-19
    • HIV
    • RSV
    • Vaccines
  • Mental Health
    • Major Depressive Disorder
    • Sleep
  • Neurology
    • Duchenne Muscular Dystrophy
    • Epilepsy
    • Multiple Sclerosis
    • Parkinson Disease
  • Obesity
  • Oncology
    • Breast Cancer
    • Cholangiocarcinoma
    • Colorectal Cancer
    • Immuno-Oncology
    • Liver Cancer
    • Non–Small Cell Lung Cancer
    • Ovarian Cancer
    • Prostate Cancer
    • Skin Cancer
    • Small Cell Lung Cancer
    • Soft Tissue Sarcoma
  • Ophthalmology
  • Pulmonology
    • COPD
    • Pulmonary Arterial Hypertension
  • Rare Disease
    • Spinal Muscular Atrophy
  • Respiratory
    • Asthma
    • Pulmonary Fibrosis
  • Rheumatology
  • Urology
    • Overactive Bladder
  • Women's Health
    • Endometriosis
  • Biosimilars
  • Bispecifics Network
  • Center on Health Equity & Access
  • Digital Health
  • Dosing & Delivery Innovations
  • Formulary
  • Gene Therapy
  • Guidelines
  • Health Care Administration
    • Employers
    • Medicare
    • Reimbursement
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Population Health
  • Product Approvals and Launches
  • Technology
  • Value-Based Care
Spotlight -
Free In-Person Regional Events Focused on Oncology and Population Health
Advertisement

James Frisbie, MD

Advertisement

Articles by James Frisbie, MD

AJMC

Incidence and Cost of Potentially Avoidable Emergency Department Visits for Urolithiasis

BySara Jordan Chadwick, MD, MPH,Om Dave, BS,James Frisbie, MD,Charles D. Scales Jr, MD, MSHS,Matthew E. Nielsen, MD, MS,David F. Friedlander, MD, MPH
November 10th 2023

This study characterizes the incidence and associated factors of urolithiasis-related emergency department visits that are potentially preventable with appropriate ambulatory care and calculates their cumulative costs.

Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on AJMC

    1

    Tec-Dara Demonstrates Superior 3-Year PFS vs Standard Therapy in Functional High-Risk Myeloma: Rahul Banerjee, MD

    2

    MRD-Guided CLL Treatment Duration: Personalization or Malpractice?

    3

    Global Hematology Trials Ensure Research Stays Applicable, Flexible, Patient-Centered

    4

    Blinatumomab Improves Outcomes, Toxicity in High-Risk Pediatric ALL: Martin Schrappe, MD, PhD

    5

    frontMIND Trial Shows PFS Benefit With Tafasitamab, Lenalidomide Combo in High-Risk DLBCL: Umberto Vitolo, MD

    Brand Logo
    • About
    • Contact
    • Editorial Boards
    • Advertise
    • Do Not Sell My Information
    • Terms & Conditions
    • Privacy Policy

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    © 2026 MJH Life Sciences®

    All rights reserved.

    Secondary Brand Logo
    Alt TextAlt Text